OraSure Technologies Inc (OSUR) stock price

OraSure Technologies Inc (OSUR) is a Healthcare · Medical Instruments & Supplies company listed on NASDAQ. Price $3.50 (+0.29%), Market cap $0.21B, 52-week low–high $2.11 ~ $3.48.

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents;

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for OraSure Technologies Inc are updated in real time on BlackAll Trade.

OraSure Technologies Inc financial summary

Analyst outlook

Key ratios · profitability · growth

Frequently asked questions

What is the current OraSure Technologies Inc (OSUR) stock price?

OraSure Technologies Inc trades at $3.50 (+0.29%). Real-time quotes and charts are available on BlackAll Trade.

What is the OraSure Technologies Inc (OSUR) market cap?

OraSure Technologies Inc has a market cap of about $0.21B.

What does OraSure Technologies Inc (OSUR) do?

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Af